Acquired Genetic Changes In Cancer Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are the three categories of acquired genetic change in cancer?

A
  1. Formation of a chimaeric protein
  2. Gain/amplification (of gene/gene product)
  3. Deletion/loss of function of a gene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Provide some details on the formation of a chimaeric protein in the context of oncology cytogenetics

A
  • balanced rearrangement (e.g. Translocations, inversions, insertions)
  • Fusion of two genes results in production of chimaeric protein
  • Usually involves a TF: change to control mechanism means it is continuously switched on
  • Cascade of other genes then switched on
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are some examples in oncology involving formation of chimaeric proteins?

A
  • t(9;22) in CML (Philadelphia chr; BCR/ABL1)
  • t(15;17) in APML (PML/RARA)
  • Inv(16) in AML (CBFB/MYH11)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Increase of a gene or gene product in oncology can be subdivided into which two categories?

A
  • Increase in copy number of an oncogene (arises through unbalanced abnormality)
  • Increase in expression of an oncogene (arises through balanced abnormality)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Provide details on increase of a gene or gene product arising through increase in the copy number of an oncogene

A

Gain of copies of gene(s) by unbalanced cytogenetic abnormality, which can include:

  • Dup of part of/whole chromosome
  • Amp of smaller DNA segment including oncogene in form of double minutes/homogenous staining regions (=many fold increase in copy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Give some examples of an increase of a gene or gene product arising through increase in copy number of an oncogene

A
  • Trisomy8 in MDS/AML

- Neuroblastoma (amp results in increased copy number more than 4-fold relative to ploidy level)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are double minutes in the context of oncology?

A
  • Small, circular frags of extrachromosomal DNA observed in large number of tumours
  • no centromere/telomere, replicate in nucleus during cell division
  • Often contain amplified oncogenes or genes involved in drug resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Provide details on increase of a gene or gene product arising through increase in the expression of an oncogene

A
  • Balanced rearrangement can place unaltered oncogene next to promoter region of another highly transcribed gene resulting in massive upregulation of the oncogene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two subtypes of loss of a gene or gene product in the context of oncology cytogenetics?

A
  1. loss of tumour suppressor gene (common) - both copies usually compromised within tumour
  2. haploinsufficiency for dosage sensitive gene(s)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the different mechanisms behind loss of a gene or gene product in oncology cytogenetics?

A
  • Loss of whole chr (unbalanced)
  • Deletion of part of chr (unbalanced)
  • mutation within a gene (balanced)
  • loss of heterozygosity (balanced)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Provide some examples of loss of a gene or gene product in cancer cytogenetics

A
  1. RB1 (tumour suppressor gene) - patients with bilateral retinoblastoma usually have constitutional mutation in one copy, when other copy is mutated/lost retinoblastoma develops
  2. TP53 (TSG) located at 17p = guardian of the genome - patients with constitutional mutations of TP53 have Li Fraumeni syndrome with very high risk of developing cancer (P53 loss seen in many)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 5 main methods of detecting genetic changes in oncology?

A
  1. Conventional cytogenetics
  2. FISH
  3. PCR
  4. Microarray
  5. NGS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the pros and cons of using cytogenetics for detecting genetic changes in oncology?

A

Pros
- gives undirected, whole genome screen for that cell
- detects balanced and unbalanced abnormalities
- WHO disease classes are linked to cytogenetics
Cons
- requires fresh tissue to provide dividing cells
- requires experienced analyst as can be complex and difficult to interpret

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Give some examples of probe types used in oncology FISH

A
  • Two colour colocalisation FISH
  • Two colour dual fusion probes (e.g. BCR/ABL1)
  • Two colour split apart probes (e.g. MLL)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the pros of using FISH for oncology testing?

A
  • can be used on metaphase preps or non-dividing cells
  • can be used on archive material e.g. PETs
  • large numbers of cells can be scored
  • detects balanced and unbalanced abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the cons of using FISH for oncology testing?

A
  • Very directed - answers single specific q
  • unexpected signal patterns hard to interpret
  • low level abnormal signal patterns may be hard to distinguish from artefact
17
Q

What are the pros and cons of using PCR for oncology genetic testing?

A

Pros
- Quick and cheap
- used to quantify low level minimal residual disease
Cons
- very directed
- can’t easily detect rearrangements with many variable partners (e.g. MLL)

18
Q

Provide some basic details on CGH microarrays in the context of oncology genetics?

A
  • Microarray target slide carries multiple spots each containing different DNA targets
  • test and control DNAs co-hybridised onto microarray slide (neoplastic tissue vs normal tissue from same patient)
19
Q

What are expression arrays in the context of cancer genetic testing?

A
  • Microarray with cDNA probes spotted onto the array
  • Test sample is either RNA or cDNA from a tumour
  • Control may be derived from normal tissue from same patient
  • microarray indicates which genes are being expressed
20
Q

What are SNP arrays in the context of cancer genetic testing?

A
  • same basic technique as CGH arrays
  • allow detection of LOH (=acquired UPD; dup of one allele and loss of the other) as well as imbalance
  • LOH is an important mechanism for TSGs
21
Q

What are pros and cons of DNA microarrays for cancer genetic testing?

A

Pros
- Can be tailor made for specific uses (e.g. All known TSGs, oncogenes etc)
- many different loci can be screened in single test
- high resolution
Cons
- can’t detected balanced abnormalities
- unreliable results if sample contaminated with normal cells (many tumour samples will be)
- high cost

22
Q

Provide some basic details on NGS in context of cancer genetic testing

A
  • Sequences entire DNA sequences so in theory could detect balanced/unbalanced rearrangements and LOH
  • Potential for very high throughput but set up costs are high so services likely to be centralised
  • Like arrays it needs uncontaminated target DNA